Cargando…
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010
IMPORTANCE: Anthracyclines increase the risk for congestive heart failure (CHF); however, long-term cumulative incidence and risk factors for CHF after anthracycline therapy are not well defined in population-based studies. OBJECTIVE: To compare the long-term cumulative incidence of CHF in patients...
Autores principales: | Larsen, Carolyn M., Garcia Arango, Mariana, Dasari, Harika, Arciniegas Calle, Maria, Adjei, Effie, Rico Mesa, Juan, Scott, Christopher G., Thompson, Carrie A., Cerhan, James R., Haddad, Tufia C., Goetz, Matthew P., Herrmann, Joerg, Villarraga, Hector R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898820/ https://www.ncbi.nlm.nih.gov/pubmed/36735254 http://dx.doi.org/10.1001/jamanetworkopen.2022.54669 |
Ejemplares similares
-
Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer
por: Arciniegas Calle, Maria C., et al.
Publicado: (2018) -
The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity
por: Ibanez, Borja, et al.
Publicado: (2022) -
A male with multiple cardiac masses
por: Indrabhinduwat, Manasawee, et al.
Publicado: (2018) -
Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
por: Moossavi, Maryam, et al.
Publicado: (2023) -
Newborn Screening Services in Bahrain between 1985 and 2010
por: Al Arrayed, Shaikha, et al.
Publicado: (2012)